Art Taveras

Art Taveras

No open positions remaining
62 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Art Taveras was previously employed as a Chief Scientific Officer by X4 Pharmaceuticals, Inc., a Chief Scientific Officer by Comet Therapeutics, Inc., a Chief Scientific Officer & Head-Drug Discovery by Transform Therapeutics, a President & Chief Scientific Officer by Shanghai ChemPartner Co., Ltd., a Vice President-Small Molecule Drug Discovery by Biogen Idec, Inc. (North Carolina), and a Vice President-Drug Discovery & Development by Alantos Pharmaceuticals Holding, Inc. He received his undergraduate degree from Rensselaer Polytechnic Institute, a graduate degree from Rensselaer Polytechnic Institute and a doctorate degree from Rensselaer Polytechnic Institute.

Former positions of Art Taveras

CompaniesPositionEnd
X4 PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01/01/2025
Transform Therapeutics
Founder 01/11/2020
Chief Tech/Sci/R&D Officer 01/07/2020
President 01/12/2014
Corporate Officer/Principal 01/01/2013
See the detail of Art Taveras's experience

Training of Art Taveras

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

10

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Transform Therapeutics